Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Treatment of Children After Intrauterine Growth Retardation

NCT01697644 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01697644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01697644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Treatment of Children After Intrauterine Growth Retardation
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
October 31, 1990
Completion date
May 31, 2005
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

foetal growth problem, small for gestational age